A
Alaunos Therapeutics, Inc. (TCRT)
NCM – Real Time Price. Currency in USD
2.08
+0.01 (0.48%)
At close: Jun 26, 2026, 4:00 PM EDT
2.41
+0.33 (15.87%)
After-hours: Jun 26, 2026, 7:38 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
2.08
+0.01 (0.48%)
At close: Jun 26, 2026, 4:00 PM EDT
2.41
+0.33 (15.87%)
After-hours: Jun 26, 2026, 7:38 PM EDT
No Data
There are no news for this stock.
Cash reserves $354.0K barely cover the upcoming debt maturities $0.0
Total current assets $970.0K exceed Total current liabilities $595.0K, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$1.0M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.63 | 6.05 | 8.0 | |
| Quick ratio | 1.63 | 5.63 | 8.0 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 3M | 5K | 10K | 5K | 3K |
| Gross Profit | 163K | -2M | 8K | -2K | -12K |
| Operating Income | -35M | -28M | -5M | -4M | -4M |
| Net Income | -38M | -35M | -5M | -4M | -4M |
| EBITDA | -32M | -26M | -5M | -4M | -4M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | N/A | N/A | 1.0 |
| Next year | 151.81 | 14.29 | 9.0 |
| Weighted average score | 3.0 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -99.99 | -12.64 | N/A | -86.43 | 1.0 |
| Y/Y | -99.99 | 6.24 | N/A | -33.54 | 2.0 |
| 3y average | -16.59 | 34.76 | N/A | 40.3 | 5.5 |
| 5y average | 316.67 | 31.58 | N/A | 35.69 | 7.8 |
| Weighted average score | 4.1 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |